Sofosbuvir

FDA Approves Vosevi for Patients With Chronic HCV

The FDA has approved Vosevi (sofosbuvir-velpatasvir-voxilaprevir, Gilead Sciences), a single-tablet pangenotypic ...

JULY 19, 2017

Load more